Global endometrial ablation market will reach $4,065.8 million by 2032, growing by 4.7% annually over 2022-2032, driven by the huge prevalence of Gynecological disorders and growing cases of cervical cancer, emergence of next generation ablation procedures and minimally invasive surgical techniques, the benefits of Endometrial Ablation over Hysterectomy (surgical removal of the uterus), growing adoption of ablation procedures, and the government initiatives for the development of the healthcare sector.

Highlighted with 81 tables and 70 figures, this 145-page report “Global Endometrial Ablation Market 2022-2032 by Offering (Devices, Procedures), Technology (Radiofrequency, Cryoablation, Hydrothermal, Thermal Balloon, Hysteroscopic, Microwave Energy, Electrical), End User (Hospitals, Clinics, ASCs), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global endometrial ablation market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces


The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global endometrial ablation market in every aspect of the classification from perspectives of Offering, Technology, End User, and Region.

Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Devices
  • Procedures


Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Radiofrequency Ablation
  • Cryoablation
  • Hydrothermal Ablation
  • Thermal Balloon
  • Hysteroscopic Ablation
  • Microwave Energy
  • Electrical Ablators


By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers (ASCs)


Geographically, the following regions together with the listed national/local markets are fully investigated:

  • North America (U.S., Canada, and Mexico)
  • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
  • South America (Brazil, Colombia, Argentina, Rest of South America)
  • MEA (UAE?Saudi Arabia? South Africa and Rest of MEA)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and split of each national market by Offering, Technology and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
AngioDynamics Inc.
Boston Scientific Corporation
Cooper Surgical Inc.
Ethicon, Inc. (Johnson & Johnson)
Hologic, Inc.
Karl Storz GmbH & Co. KG
Medtronic Plc
Minerva Surgical, Inc.
Olympus Corporation
Richard Wolf GmbH
Smith & Nephew Plc
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)